Skip to main content
. 2004 Mar 29;101(14):4990–4995. doi: 10.1073/pnas.0400880101

Fig. 2.

Fig. 2.

Therapeutic efficacy against s.c. established M2-WT tumors by immunization with live (A) or MMC-treated (B) M2-CD83 cells as indicated. (Left) Tumor growth. (Right) Survival rates. (n = 5 mice per group.)